US2019365823A1PendingUtilityA1

Encapsulated intestinal midgut endoderm cells

Assignee: JANSSEN BIOTECH INCPriority: Apr 14, 2016Filed: Aug 14, 2019Published: Dec 5, 2019
Est. expiryApr 14, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61P 3/10C12N 2501/727C12N 2500/38C12N 2501/19A61K 35/545C12N 2501/119A61K 35/38C12N 2501/415C12N 5/0679C12N 2506/02C12N 2501/385C12N 2501/155C12N 2506/45C12N 2501/72C12N 2501/10C12N 2501/602C12N 2501/60C12N 2501/30C12N 2501/16C12N 2501/117C12N 2500/60C12N 2500/30C12N 5/0603C12N 5/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Cell populations of intestinal midgut endoderm cells and methods of generating the cells expressing markers characteristic of intestinal endoderm lineage are disclosed. Methods of treating conditions such as diabetes are also disclosed.

Claims

exact text as granted — not AI-modified
1 . A population of substantially intestinal midgut endoderm cells, wherein the population of cells is encapsulated. 
     
     
         2 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the population of cells is micro-encapsulated. 
     
     
         3 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the population cells is macro-encapsulated. 
     
     
         4 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the intestinal midgut endoderm cells express CDX2 and FOXA2. 
     
     
         5 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the intestinal midgut endoderm cells express transcription factors selected from the group consisting of SOX9, PDX1, KLF5 and HOXC5. 
     
     
         6 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the intestinal midgut endoderm cells do not express transcription factors selected from the group consisting of SOX2, ALB, PTF1A, HOXA13 and LGR5. 
     
     
         7 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the intestinal midgut endoderm cells do not express HAND1. 
     
     
         8 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the population comprises greater than 70% intestinal midgut endoderm cells. 
     
     
         9 . The population of substantially intestinal midgut endoderm cells of  claim 8 , wherein the population comprises greater than 80% intestinal midgut endoderm cells. 
     
     
         10 . The population of substantially intestinal midgut endoderm cells of  claim 8 , wherein the population comprises greater than 90% intestinal midgut endoderm cells. 
     
     
         11 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the population comprises less than 20% mesenchymal cells. 
     
     
         12 . The population of substantially intestinal midgut endoderm cells of  claim 11 , wherein the population comprises less than 10% mesenchymal cells. 
     
     
         13 . The population of substantially intestinal midgut endoderm cells of  claim 11 , wherein the population comprises less than 1% mesenchymal cells. 
     
     
         14 . The population of substantially intestinal midgut endoderm cells of  claim 1 , wherein the population does not include mesenchymal cells.

Join the waitlist — get patent alerts

Track US2019365823A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.